102 related articles for article (PubMed ID: 28714190)
1. Polymorphisms of xenobiotic-metabolizing genes and colorectal cancer risk in patients with lynch syndrome: A retrospective cohort study in Taiwan.
Kamiza AB; You JF; Wang WC; Tang R; Chang CY; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
Environ Mol Mutagen; 2018 Jan; 59(1):69-78. PubMed ID: 28714190
[TBL] [Abstract][Full Text] [Related]
2. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
[TBL] [Abstract][Full Text] [Related]
4.
Kamiza AB; Wang WC; You JF; Tang R; Wang YT; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
Anticancer Res; 2018 Oct; 38(10):5983-5990. PubMed ID: 30275229
[TBL] [Abstract][Full Text] [Related]
5. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
[TBL] [Abstract][Full Text] [Related]
7. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
[TBL] [Abstract][Full Text] [Related]
8. SNP association study in PMS2-associated Lynch syndrome.
Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of DNA repair genes are associated with colorectal cancer in patients with Lynch syndrome.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
Mol Genet Genomic Med; 2018 Apr; 6(4):533-40. PubMed ID: 29664240
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
Özhan G; Mutur M; Ercan G; Alpertunga B
Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome.
Sotamaa K; Liyanarachchi S; Mecklin JP; Järvinen H; Aaltonen LA; Peltomäki P; de la Chapelle A
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6840-4. PubMed ID: 16203772
[TBL] [Abstract][Full Text] [Related]
14. MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.
Reeves SG; Meldrum C; Groombridge C; Spigelman AD; Suchy J; Kurzawski G; Lubinski J; McElduff P; Scott RJ
Eur J Hum Genet; 2009 May; 17(5):629-35. PubMed ID: 19156174
[TBL] [Abstract][Full Text] [Related]
15. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland.
Campbell PT; Edwards L; McLaughlin JR; Green J; Younghusband HB; Woods MO
Clin Cancer Res; 2007 Jul; 13(13):3783-8. PubMed ID: 17606708
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
18. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
19. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility genetic variants associated with early-onset colorectal cancer.
Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
